Manufacturer:
Johnson & Johnson
Route of Administration:
Intravenous, Subcutaneous
Site of Care:
Outpatient
Website:
phone:
844-4withMe (844-494-8463)
Approved Indication:
- treatment of adult patients with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy
- treatment of active psoriatic arthritis in adults
- treatment of moderately-to-severely active Crohn’s disease in adults
- treatment of moderately-to-severely active ulcerative colitis in adults
Conditions:
- Crohn’s Disease
- Plaque Psoriasis
- Psoriatic Arthritis
- Ulcerative Colitis
Therapeutic Area:
- Dermatology
- Gastroenterology
- Rheumatology